➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Medtronic
Colorcon
McKesson
McKinsey

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LITHOBID

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Lithobid

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00183443 ↗ Treatment of Mania Symptoms With Drug Therapy Completed National Institute of Mental Health (NIMH) Phase 3 2005-02-01 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00183443 ↗ Treatment of Mania Symptoms With Drug Therapy Completed Palo Alto Veterans Institute for Research Phase 3 2005-02-01 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00601536 ↗ Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions Completed Roxane Laboratories N/A 2003-04-01 The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fasting conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lithobid

Condition Name

Condition Name for Lithobid
Intervention Trials
Bipolar Disorder 4
Bipolar Affective Disorder 1
Asthma: [Nos] or [Attack] 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lithobid
Intervention Trials
Bipolar Disorder 5
Depressive Disorder 3
Depression 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lithobid

Trials by Country

Trials by Country for Lithobid
Location Trials
United States 14
Sweden 2
Norway 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lithobid
Location Trials
Texas 2
Pennsylvania 2
California 2
Minnesota 1
New Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lithobid

Clinical Trial Phase

Clinical Trial Phase for Lithobid
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lithobid
Clinical Trial Phase Trials
Completed 4
Unknown status 1
Enrolling by invitation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lithobid

Sponsor Name

Sponsor Name for Lithobid
Sponsor Trials
Roxane Laboratories 2
Örebro County Council 1
Montana State University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lithobid
Sponsor Trials
Other 13
Industry 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Dow
Colorcon
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.